<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02340650</url>
  </required_header>
  <id_info>
    <org_study_id>HSC-MS-14-0144</org_study_id>
    <nct_id>NCT02340650</nct_id>
  </id_info>
  <brief_title>High Resolution Imaging for Early and Better Detection of Bladder Cancer</brief_title>
  <acronym>HRME_Bladder</acronym>
  <official_title>High Resolution Imaging for Early and Better Detection of Bladder Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The University of Texas Health Science Center, Houston</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>William Marsh Rice University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The University of Texas Health Science Center, Houston</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to develop, optimize, and validate a High Resolution Imaging System&#xD;
      in the bladder that displays images in real-time, providing automated diagnostic criteria for&#xD;
      bladder cancer screening. High resolution images of normal bladder tissue and suspicious&#xD;
      bladder lesions will be collected from patients who present to the study site for clinical&#xD;
      evaluation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2015</start_date>
  <completion_date type="Actual">September 30, 2020</completion_date>
  <primary_completion_date type="Actual">September 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Specificity of Bladder Cancer Detection Imaging</measure>
    <time_frame>baseline (at the time of imaging)</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">37</enrollment>
  <condition>Bladder Cancer</condition>
  <arm_group>
    <arm_group_label>Bladder Cancer Patients</arm_group_label>
    <description>High resolution images of normal bladder tissue and suspicious bladder lesions will be collected from patients who present to the study site for clinical evaluation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard High Resolution Microendoscope and/or Line-Scanning Confocal High Resolution Microendoscope</intervention_name>
    <arm_group_label>Bladder Cancer Patients</arm_group_label>
    <other_name>HRME and/or LSC-HRME</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Potential subjects will be identified from patients who are visiting Lyndon B. Johnson&#xD;
        Hospital (LBJ) Houston for evaluation of bladder cancer or a suspicious bladder&#xD;
        lesion/clinical symptomatology by cystoscopy and bladder biopsy or from LBJ patients who&#xD;
        are undergoing cystoscopy as part of their routine clinical care.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosed with clinically suspicious bladder lesion or clinical finding; or who are&#xD;
             undergoing cystoscopy as part of their routine clinical care.&#xD;
&#xD;
          -  Must be willing and able to participate and provide written informed consent&#xD;
&#xD;
          -  Women of childbearing age who have the possibility of being pregnant must have a&#xD;
             negative pregnancy test prior to participation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with sufficient evidence of cognitive impairment that limits the subject's&#xD;
             ability to understand the protocol, provide informed consent, or to comply with the&#xD;
             protocol procedures.&#xD;
&#xD;
          -  Women with the possibility of having the pregnancy.&#xD;
&#xD;
          -  Patients having acute infection.&#xD;
&#xD;
          -  Person with Lidocaine sensitivity.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nadeem N Dhanani, MD MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Texas Health Science Center, Houston</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lyndon B. Johnson General Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77026</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>January 13, 2015</study_first_submitted>
  <study_first_submitted_qc>January 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 16, 2015</study_first_posted>
  <last_update_submitted>June 22, 2021</last_update_submitted>
  <last_update_submitted_qc>June 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The University of Texas Health Science Center, Houston</investigator_affiliation>
    <investigator_full_name>Nadeem N Dhanani</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>suspicious bladder lesion, normal bladder tissue</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urinary Bladder Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

